CTOs on the Move

Viz

www.viz.ai

 
In 2015, five seminal randomized controlled trials were published in the neurovascular space demonstrating endovascular thrombectomy to be the new gold standard for treating large vessel occlusion strokes. During that same year, advancements in artificial intelligence and deep learning made it possible to analyze medical imaging rapidly and accurately. However, despite having proven effective interventions for stroke, most stroke patients were getting treatment late or not at all. At Stanford University, Dr. Chris Mansi (neurosurgeon) and Dr. David Golan (machine learning researcher) identified this problem and together they sought to change it.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.viz.ai

  • San Francisco, CA USA
  • Phone: 866.849.4980

Executives

Name Title Contact Details
Gad Sakin
 CTO Profile

Funding

Viz raised $21M on 07/18/2018
Viz raised $50M on 10/23/2019
Viz raised $71M on 03/17/2021

Similar Companies

Lancer Orthodontics

Lancer Orthodontics is a Vista, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CoolSystems

CoolSystems, Inc. is a Alameda, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ClearPoint Neuro

Our mission is to improve and restore quality of life to patients and their families by enabling therapies for the most complex neurological disorders with pinpoint accuracy. Applications of our current product portfolio include deep-brain stimulation, laser ablation, biopsy, neuro-aspiration, and delivery of drugs, biologics and gene therapy to the brain.

HowDu

HowDu is a New Rochelle, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Haemonetics

We believe that through proper blood management, our products and services can help our commercial plasma and blood center customers optimize their collection processes. We seek to help ensure a continual supply of high-quality plasma for biopharmaceuticals and blood components for therapeutic use at optimal costs, along with better blood management processes. Working with our hospital customers, we seek to prevent a blood transfusion to the patient who doesn’t need one, or, if a transfusion is necessary, to ensure the transfusion of the right blood product, at the right time, in the right dose to the patient who does.